CF suppresses cell growth by apoptosis in MSTO-211 and HCT-116 ce

CF suppresses cell growth by apoptosis in MSTO-211 and HCT-116 cell lines. In particular, we found that CF caused an increase of sub-G1 and a reduction of G1 in MSTO-211, and a cell cycle arrest in G1 in HCT116. We speculated that CF-induced proliferative block was irreversible due to the significant increase in population #Y27632 randurls[1|1|,|CHEM1|]# with a sub-G1 and G1 DNA content (that are indicative of apoptosis) observed in the treated cells as compared to the untreated ones. Evidence of apoptosis in MSTO-211 and HCT-116 cells on CF treatment was observed in western blot. CF induces apoptosis by a caspase-dependent pathway.

Among the caspase family members, caspase-3 is known to be one of the key executioners of apoptosis because caspase-3 activation causes the cleavage or degradation of downstream important substrates, like PARP, which is the hallmark of caspase-dependent apoptosis. In our experiments, caspase-3 activation and PARP cleavage were detected in CF-treated MSTO-211 and HCT-116. Thus, apoptosis induction by CF was

also confirmed by these observations. Nevertheless, to further explain the precise mechanism of CF-induced apoptosis in cancer cells, we examined the expression levels of p53, c-myc, Bcl-2, pAkt and Akt. We identified p53 as the target of CF. p53 is one of the most important tumour suppressor genes, and it is frequently inactivated in various cancers. p53 modulates Cl-amidine various cellular functions, such as apoptosis and cell cycle arrest via transcriptional regulation. Interestingly, wild-type

p53 expression was detected in 47% of colorectal adenocarcinomas [46], and approximately 70–80% of mesothelioma cells, although having the wild-type p53 gene, show a homologous deletion at the INK4A/ARF locus containing the p14ARF and the p16INK4A genes, which consequently leads to decreased p53 functions despite the wild-type genotype [47]. MSTO-211 and HCT-116 cell lines endowed wild-type p53 and CF treatment increased the expression level of p53. Accumulating evidence indicates that c-myc has an important function in cell proliferation and apoptosis induction PtdIns(3,4)P2 [48]. c-Myc expression is low in quiescent normal cells whereas it is elevated in a broad range of human cancers, such as the malignant pleural mesothelioma, indicating its key role in tumour development [49]. Human malignant pleural mesothelioma shows elevated c-myc expression and it is a transcription factor mediating cancer progression, highly overexpressed in 60% of colorectal cancer, indicating that c-myc is a hallmark of tumorigenesis [50–52]. Studies using conventional c-myc transgenic mice, in which the oncogene is constitutively expressed in a given cell type by means of a tissue-specific promoter, have supported the view that deregulated c-myc, as an initial event, is important for the formation of certain cancers, albeit with a long latency [24, 53, 54].

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>